Follow-up of “negative for malignancy” biopsies
| Patients’ Characteristics and Lesion Management | No. | % |
|---|---|---|
| Initially “negative for malignancy” biopsies | 43/184 | 23% |
| Patients with a known malignancy | 29/43 | 68% |
| Rebiopsied/excised | 7/29 | 20% |
| Ultimately +malignancy | 4/7 | 57% |
| Stable/resolved (mean f/u time: 32 mo, 2–120 mo) | 17/29 | 59% |
| No f/u | 5/29 | 17% |
| Patients without known malignancy | 14/43 | 32% |
| Rebiopsied/excised | 5/14 | 36% |
| Ultimately + malignancy | 0/5 | 0% |
| Stable/resolved (mean f/u time: 25.6 mo, 1–72 mo) | 7/14 | 50% |
| No f/u | 2/14 | 14% |
| Total false-negative rate | 4/184 | 2% |
| Total diagnostic yield | 167/184 | 91% |
Note:—f/u indicates follow-up.